FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+8.3%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$20.6B
AUM Growth
+$69.2M
(+0.34%)
Cap. Flow
-$923M
Cap. Flow
% of AUM
-4.47%
Top 10 Holdings %
Top 10 Hldgs %
46.31%
Holding
486
New
61
Increased
155
Reduced
192
Closed
52
Top Buys
| 1 |
GFL Environmental
GFL
|
$159M |
| 2 |
Broadcom
AVGO
|
$138M |
| 3 |
Astera Labs
ALAB
|
$138M |
| 4 |
Tesla
TSLA
|
$124M |
| 5 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$67.3M |
Top Sells
| 1 |
Natera
NTRA
|
$159M |
| 2 |
Marvell Technology
MRVL
|
$156M |
| 3 |
McKesson
MCK
|
$119M |
| 4 |
Mercado Libre
MELI
|
$106M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$93.3M |
Sector Composition
| 1 | Technology | 38.32% |
| 2 | Healthcare | 14.56% |
| 3 | Communication Services | 13.24% |
| 4 | Industrials | 12.02% |
| 5 | Consumer Discretionary | 11.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Consolidated Edison
ED
$35.4B
| $3.67M | 0.02% |
35,228
+3,834
| +12% | +$399K |
|
277
Procore
PCOR
$10.5B
| $3.62M | 0.02% |
58,622
-37,809
| -39% | -$2.33M |
|
278
Weatherford International
WFRD
$4.49B
| $3.58M | 0.02% |
42,118
+41,448
| +6,186% | +$3.52M |
|
279
Guardant Health
GH
$7.5B
| $3.57M | 0.02% |
155,429
-43,039
| -22% | -$987K |
|
280
Denali Therapeutics
DNLI
$2.26B
| $3.53M | 0.02% |
121,316
+94,302
| +349% | +$2.75M |
|
281
JD.com
JD
$44.6B
| $3.5M | 0.02% |
+87,439
| New | +$3.5M |
|
282
Keros Therapeutics
KROS
$633M
| $3.43M | 0.02% |
59,138
+10,145
| +21% | +$589K |
|
283
Cardinal Health
CAH
$35.7B
| $3.43M | 0.02% |
31,052
+1,383
| +5% | +$153K |
|
284
CyberArk
CYBR
$23.3B
| $3.39M | 0.02% |
11,626
-137
| -1% | -$40K |
|
|
AZEK
285
DELISTED
The AZEK Co
AZEK
| $3.36M | 0.02% |
71,742
+3,573
| +5% | +$167K |
|
286
Medtronic
MDT
$119B
| $3.31M | 0.02% |
36,801
+2,390
| +7% | +$215K |
|
287
AutoZone
AZO
$70.6B
| $3.26M | 0.02% |
1,034
-249
| -19% | -$784K |
|
288
Savers
SVV
$1.96B
| $3.2M | 0.02% |
304,249
-12,186
| -4% | -$128K |
|
289
Prologis
PLD
$105B
| $3.13M | 0.02% |
24,814
| – | – |
|
290
Celsius Holdings
CELH
$15B
| $3.09M | 0.02% |
98,402
-56,755
| -37% | -$1.78M |
|
|
BPMC
291
DELISTED
Blueprint Medicines
BPMC
| $3.06M | 0.01% |
33,110
-15,478
| -32% | -$1.43M |
|
292
Novartis
NVS
$251B
| $3.02M | 0.01% |
26,295
| – | – |
|
293
Elevance Health
ELV
$70.6B
| $2.98M | 0.01% |
5,730
-6,881
| -55% | -$3.58M |
|
294
Pfizer
PFE
$141B
| $2.97M | 0.01% |
102,668
+7,076
| +7% | +$205K |
|
295
Encompass Health
EHC
$12.6B
| $2.96M | 0.01% |
30,641
+479
| +2% | +$46.3K |
|
296
Structure Therapeutics
GPCR
$1.27B
| $2.93M | 0.01% |
66,713
-220,923
| -77% | -$9.7M |
|
297
Biohaven
BHVN
$1.68B
| $2.91M | 0.01% |
58,142
+17,848
| +44% | +$892K |
|
298
Merus
MRUS
$5.1B
| $2.89M | 0.01% |
57,946
-4,870
| -8% | -$243K |
|
299
908 Devices
MASS
$196M
| $2.85M | 0.01% |
820,448
-185,789
| -18% | -$645K |
|
|
CNTA
300
Centessa Pharmaceuticals
CNTA
$2.11B
| $2.84M | 0.01% |
177,553
+166,560
| +1,515% | +$2.66M |
|